Human Medicine:

COVID-19 (CORONAVIRUS) TESTING

SYNLAB offer multiple COVID-19 (Coronavirus) testing options to assist our clients in supporting their clients / employees / patients whether they are symptomatic or asymptomatic utilising testing capacity within SYNLAB Group.

SYNLAB’s COVID-19 testing delivers results with full clinical oversight, all test options can be used independently or as part of an ongoing patient / workplace testing programme.

COVID-19 PCR Swab Test (PCR-RNA SARS-CoV-2)
  • Throat and nasal swab.
  • Test can be taken if have active symptoms or have been in contact with someone with COVID-19.
  • Indicates if someone currently has COVID-19.
COVID-19 IgG / IgM Antibody Test (SARS-CoV-2)
  • Blood test.
  • Test to be taken 20+ days from the onset of symptoms or exposure.
  • Detects COVID-19 antibodies which indicate if someone has had COVID-19.
COVID-19 IgG / IgM Rapid Test
  • Finger prick blood test.
  • Detects COVID-19 antibodies which indicate if have had COVID-19.
  • Approved by MHRA for professional use only in the UK.
  • Results within 10-15 minutes.

Blood samples must be taken by a qualified healthcare professional for both the COVID-19 Rapid Test and back to laboratory COVID-19 Antibody Blood Test. SYNLAB has professional healthcare partners available across the UK to assist with onsite sample collections for blood and PCR swab samples. 

For further details on our tests and how we can support you with COVID-19 testing please click here or contact us on [email protected] or 01873 856688.

For the latest UK Government COVID-19 guidance and symptoms visit www.gov.uk/coronavirus

Latest Human Medicine News
Press Statement: SYNLAB UK & Ireland Announced As Partner In Major Pathology Partnership Contract

6th October 2020 We are delighted to announce that SYNLAB UK & Ireland will become the new pathology partner to Guy’s and St Thomas’ NHS…

Read More (about 'Press Statement: SYNLAB UK & Ireland Announced As Partner In Major Pathology Partnership Contract')
SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing

13 July 2020 SYNLAB UK & Ireland and Arquer Diagnostics, a UK-based company committed to manufacturing and marketing innovative, non-invasive tests for diagnosing and monitoring…

Read More (about 'SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing')
SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation

7th April 2020 – SYNLAB Laboratory Services, part of Europe’s leading medical diagnostics provider SYNLAB Group, is pleased to announce that the company has successfully…

Read More (about 'SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation')
Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner

21 January 2020 SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB…

Read More (about 'Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner')